• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国扩大诊断实验室的最佳时机

Optimal Timing for Expanding Diagnostic Laboratories, South Korea.

作者信息

Park Jae-Sun, Kim Gab Jung, Lee Sang Won

出版信息

Emerg Infect Dis. 2025 Aug;31(8):1-8. doi: 10.3201/eid3108.241745.

DOI:10.3201/eid3108.241745
PMID:40705365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12309759/
Abstract

The rapid expansion of testing capacity is imperative for an adequate response to infectious diseases, such as COVID-19. South Korea rapidly secured large-scale testing during the early stages of COVID-19 in 2020 by leveraging the country's experience with the 2015 Middle East respiratory syndrome outbreak; the initial response was relatively successful. A key difference between the 2 outbreak responses was the expansion from public to private testing laboratories during the COVID-19 pandemic. Expanding testing capacity during an infectious disease crisis should involve consideration of the overall response system and social conditions and not just the number of patients. If there are concerns about a crisis developing, testing capacity expansion should begin as soon as possible. Furthermore, accuracy should be ensured, especially when testing capacity is expanded. South Korea's experience in developing diagnostic systems and adopting testing strategies underscores the value of proactive and well-timed preparedness for emerging infection disease outbreaks.

摘要

迅速扩大检测能力对于充分应对诸如新冠肺炎等传染病至关重要。韩国在2020年新冠肺炎疫情早期,借助该国应对2015年中东呼吸综合征疫情的经验,迅速确保了大规模检测;初期应对相对成功。这两次疫情应对的一个关键差异在于,在新冠肺炎疫情期间检测从公共实验室扩展到了私人实验室。在传染病危机期间扩大检测能力应考虑整体应对系统和社会状况,而不仅仅是患者数量。如果担心危机出现,应尽快开始扩大检测能力。此外,尤其在扩大检测能力时应确保准确性。韩国在开发诊断系统和采用检测策略方面的经验凸显了对新发传染病疫情进行积极且及时准备的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3558/12309759/28ba0c928b5a/24-1745-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3558/12309759/86b1bd51b54d/24-1745-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3558/12309759/5c88788fe5f8/24-1745-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3558/12309759/9283ba3f23c3/24-1745-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3558/12309759/28ba0c928b5a/24-1745-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3558/12309759/86b1bd51b54d/24-1745-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3558/12309759/5c88788fe5f8/24-1745-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3558/12309759/9283ba3f23c3/24-1745-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3558/12309759/28ba0c928b5a/24-1745-F4.jpg

相似文献

1
Optimal Timing for Expanding Diagnostic Laboratories, South Korea.韩国扩大诊断实验室的最佳时机
Emerg Infect Dis. 2025 Aug;31(8):1-8. doi: 10.3201/eid3108.241745.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Effects of city design on transport mode choice and exposure to health risks during and after a crisis: a retrospective observational analysis.危机期间及之后城市设计对交通方式选择和健康风险暴露的影响:一项回顾性观察分析
Lancet Planet Health. 2025 Jun;9(6):e467-e479. doi: 10.1016/S2542-5196(25)00088-9.
5
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
8
Impact of imported COVID-19 cases on South Korea's response: variant transitions and regional patterns (2020-2023).输入性新冠病例对韩国应对措施的影响:变异株演变与区域模式(2020 - 2023年)
BMC Infect Dis. 2025 Jul 1;25(1):820. doi: 10.1186/s12879-025-11260-3.
9
Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID: A compendium statement.关于长新冠患者评估与治疗的多学科协作指南:一份概要声明
PM R. 2025 Apr 22. doi: 10.1002/pmrj.13397.
10
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.

本文引用的文献

1
Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea.韩国 COVID-19 实验室诊断指南更新。
Ann Lab Med. 2022 Jul 1;42(4):391-397. doi: 10.3343/alm.2022.42.4.391.
2
COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays.韩国的 COVID-19 分子检测:基于紧急使用授权检测经验的专家实用要点和解答
Ann Lab Med. 2020 Nov;40(6):439-447. doi: 10.3343/alm.2020.40.6.439. Epub 2020 Jun 17.
3
Preparedness and Rapid Implementation of External Quality Assessment Helped Quickly Increase COVID-19 Testing Capacity in the Republic of Korea.
外部质量评估的准备与快速实施助力韩国迅速提升新冠病毒检测能力。
Clin Chem. 2020 Jul 1;66(7):979-981. doi: 10.1093/clinchem/hvaa097.
4
Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.韩国 2019 冠状病毒病(COVID-19)实验室诊断指南。
Ann Lab Med. 2020 Sep;40(5):351-360. doi: 10.3343/alm.2020.40.5.351.
5
Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015.2015年韩国中东呼吸综合征冠状病毒疫情
Osong Public Health Res Perspect. 2015 Aug;6(4):269-78. doi: 10.1016/j.phrp.2015.08.006. Epub 2015 Sep 5.